Start your intake State-by-State Medicaid GLP-1 Coverage: What You Need to Know As of 2024, approximately 30 state Medicaid programs cover GLP-1 medications for weight loss, though many limit coverage to patients with BMI 30 kg/m plus at least one obesity-related comorbidity (hypertension, type 2 diabetes, sleep apnea, or cardiovascular disease)
Genetic variants in genes like GIPR, GLP1R, FTO, and MC4R influence how your body processes semaglutide and responds to weight loss, insights that inform personalized protocols
Animal studies involving both GH-deficient and non-GH-deficient mice have shown that twice-daily ipamorelin injections lead to significant increases in body weight (15.3% and 16.9% respectively) [8] and stimulate GH secretion, which is lipolytic [9]
AMA Free Article Guest Episode Podcast Episode Premium Article Get 100% Free Youll also receive non-lame weekly emails on the latest strategies and tactics for increasing your lifespan, healthspan, and well-being (and new podcast announcements) "*" indicates required fields Login
Long-term results are still under study
